Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease

Circulation Research

Volumn 123, Issue 9, 2018, Pages 1091-1102

  Malik, Mobin ^a   Suboc, Tisha M ^a   Tyagi, Sudhi ^a   Salzman, Nita ^b,c   Wang, Jingli ^a   Ying, Rong ^a   Tanner, Michael J ^a   Kakarla, Mamatha ^a   Baker, John E ^b,d   Widlansky, Michael E ^b,d  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Department of Pediatrics ^*  (United States)

^c Division of Congenital Cardiac Surgery   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Coronary artery disease; Endothelium; Gastrointestinal microbiome; Humans; Probiotics

Indexed keywords

ACETIC ACID; ADIPOCYTOKINE; BIOLOGICAL MARKER; GLUCOSE; INTERLEUKIN 12; INTERLEUKIN 8; PROBIOTIC AGENT; RNA 16S; SHORT CHAIN FATTY ACID; TRIMETHYLAMINE OXIDE; AUTACOID; CYTOKINE; FATTY ACID; METHYLAMINE; TRIMETHYLOXAMINE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; BODY MASS; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; FECES ANALYSIS; HUMAN; INFLAMMATION; LACTOBACILLUS PLANTARUM; LACTOBACILLUS PLANTARUM 299V; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEN'S HEALTH; PRIORITY JOURNAL; RNA SEQUENCE; VASCULAR ENDOTHELIUM; VASODILATATION; BLOOD; CLINICAL TRIAL; FECES; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; TIME FACTOR; TREATMENT OUTCOME;

ADIPOKINES; ADULT; AGED; BIOMARKERS; CORONARY ARTERY DISEASE; CYTOKINES; ENDOTHELIUM, VASCULAR; FATTY ACIDS; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION MEDIATORS; LACTOBACILLUS PLANTARUM; MALE; METHYLAMINES; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; TIME FACTORS; TREATMENT OUTCOME; VASODILATION;

EID: 85055600525     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.118.313565     Document Type: Article

References (65)

1. Ettinger G, MacDonald K, Reid G, Burton JP. The infuence of the human microbiome and probiotics on cardiovascular health. Gut Microbes. 2014;5:719-728. doi: 10.4161/19490976.2014.983775
2. Griffn JL, Wang X, Stanley E. Does our gut microbiome predict cardiovas-cular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet. 2015;8:187-191. doi: 10.1161/CIRCGENETICS.114.000219
3. Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, Mizoguchi T, Ogawa W, Hirata K. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J Atheroscler Thromb. 2016;23:908-921. doi: 10.5551/jat.32672
4. Singh M, Bedi US, Singh PP, Arora R, Khosla S. Leptin and the clinical cardiovascular risk. Int J Cardiol. 2010;140:266-271. doi: 10.1016/j.ijcard.2009.07.019
5. Wang Z, Klipfell E, Bennett BJ, et al. Gut fora metabolism of phosphati-dylcholine promotes cardiovascular disease. Nature. 2011;472:57-63. doi: 10.1038/nature09922
6. Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol. 2017;14:79-87. doi: 10.1038/nrcardio.2016.183
7. Tang WH, Hazen SL. The gut microbiome and its role in car-diovascular diseases. Circulation. 2017;135:1008-1010. doi: 10.1161/CIRCULATIONAHA.116.024251
8. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcho-line and cardiovascular risk. N Engl J Med. 2013;368:1575-1584. doi: 10.1056/NEJMoa1109400
9. Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, Mackay CR, Kaye DM. High-fber diet and acetate supplementation change the gut mi-crobiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135:964-977. doi: 10.1161/CIRCULATIONAHA.116.024545
10. Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017;5:14. doi: 10.1186/s40168-016-0222-x
11. Asselbergs FW, van der Harst P, Jessurun GA, Tio RA, van Gilst WH. Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins. Vascul Pharmacol. 2005;42:125-140. doi: 10.1016/j.vph.2005.01.009
12. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, Satomura K, Ohsuzu F, Kurita A. Endothelium-dependent fow-mediated vasodila-tion in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998;82:1535, A7-1539, A7.
13. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascu-lar risk? Circulation. 2002;106:640-642.
14. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of fow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2-H12. doi: 10.1152/ajpheart.00471.2010
15. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
16. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002;76:1249-1255. doi: 10.1093/ajcn/76.6.1249
17. Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafee P, Gross GJ, Salzman NH, Baker JE. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012;26:1727-1735. doi: 10.1096/fj.11-197921
18. Kim JY, Kim H, Jung BJ, Kim NR, Park JE, Chung DK. Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque infammation. Mol Cells. 2013;35:115-124. doi: 10.1007/s10059-013-2190-3
19. Kizhakekuttu TJ, Gutterman DD, Phillips SA, Jurva JW, Arthur EI, Das E, Widlansky ME. Measuring FMD in the brachial artery: how important is QRS gating? J Appl Physiol (1985). 2010;109:959-965. doi: 10.1152/japplphysiol.00532.2010
20. Babar GS, Zidan H, Widlansky ME, Das E, Hoffmann RG, Daoud M, Alemzadeh R. Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care. 2011;34:681-685. doi: 10.2337/dc10-2134
21. Kizhakekuttu TJ, Wang J, Dharmashankar K, Ying R, Gutterman DD, Vita JA, Widlansky ME. Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2012;32:2531-2539. doi: 10.1161/ATVBAHA.112.256024
22. Suboc T, Strath SJ, Dharmashankar K, Coulliard A, Miller N, Wang J, Tanner MJ, Widlansky ME. Relative importance of step count, intensity, and duration on physical activity's impact on vascular structure and function in previously sedentary older adults. J Am Heart Assoc. 2014;3:e000702. doi: 10.1161/JAHA.113.000702
23. Hazen TC, Dubinsky EA, DeSantis TZ, et al. Deep-sea oil plume enriches indigenous oil-degrading bacteria. Science. 2010;330:204-208. doi: 10.1126/science.1195979
24. Wang Z, Levison BS, Hazen JE, Donahue L, Li XM, Hazen SL. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. Anal Biochem. 2014;455:35-40. doi: 10.1016/j.ab.2014.03.016
25. Wang J, Alexanian A, Ying R, Kizhakekuttu TJ, Dharmashankar K, Vasquez-Vivar J, Gutterman DD, Widlansky ME. Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler Thromb Vasc Biol. 2012;32:712-720. doi: 10.1161/ATVBAHA.111.227389
26. Dharmashankar K, Welsh A, Wang J, Kizhakekuttu TJ, Ying R, Gutterman DD, Widlansky ME. Nitric oxide synthase-dependent vasodilation of human subcutaneous arterioles correlates with noninvasive measure-ments of endothelial function. Am J Hypertens. 2012;25:528-534. doi: 10.1038/ajh.2012.8
27. Tanner MJ, Wang J, Ying R, Suboc TB, Malik M, Couillard A, Branum A, Puppala V, Widlansky ME. Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arteri-oles. Am J Physiol Heart Circ Physiol. 2017;312:H515-H527. doi: 10.1152/ajpheart.00499.2016
28. Li XS, Obeid S, Klingenberg R, et al. Gut microbiota-dependent trimeth-ylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J. 2017;38:814-824. doi: 10.1093/eurheartj/ehw582
29. Atkinson G, Batterham AM. The percentage fow-mediated dilation in-dex: a large-sample investigation of its appropriateness, potential for bias and causal nexus in vascular medicine. Vasc Med. 2013;18:354-365. doi: 10.1177/1358863X13508446
30. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol. 2004;24:1503-1508. doi: 10.1161/01.ATV.0000134294.54422.2e
31. Zittermann SI, Issekutz AC. Basic fbroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to infammation by enhancing endothe-lial adhesion molecule expression. Am J Pathol. 2006;168:835-846. doi: 10.2353/ajpath.2006.050479
32. Strasly M, Cavallo F, Geuna M, Mitola S, Colombo MP, Forni G, Bussolino F. IL-12 inhibition of endothelial cell functions and angio-genesis depends on lymphocyte-endothelial cell cross-talk. J Immunol. 2001;166:3890-3899.
33. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O, Bosia A, Marchisio PC, Mantovani A. In vitro and in vivo activation of en-dothelial cells by colony-stimulating factors. J Clin Invest. 1991;87:986-995. doi: 10.1172/JCI115107
34. Rashid SK, Idris-Khodja N, Khodja NI, Auger C, Alhosin M, Boehm N, Oswald-Mammosser M, Schini-Kerth VB. Probiotics (VSL#3) prevent en-dothelial dysfunction in rats with portal hypertension: role of the angioten-sin system. PLoS One. 2014;9:e97458. doi: 10.1371/journal.pone.0097458
35. Gómez-Guzmán M, Toral M, Romero M, Jiménez R, Galindo P, Sánchez M, Zarzuelo MJ, Olivares M, Gálvez J, Duarte J. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats. Mol Nutr Food Res. 2015;59:2326-2336. doi: 10.1002/mnfr.201500290
36. Toral M, Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Utrilla MP, Garrido-Mesa N, Rodríguez-Cabezas ME, Olivares M, Gálvez J, Duarte J. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-infammatory status in obese mice. Clin Sci (Lond). 2014;127:33-45. doi: 10.1042/CS20130339
37. Tripolt NJ, Leber B, Blattl D, Eder M, Wonisch W, Scharnagl H, Stojakovic T, Obermayer-Pietsch B, Wascher TC, Pieber TR, Stadlbauer V, Sourij H. Short communication: effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and infammation in subjects with metabolic syndrome-a pilot study. J Dairy Sci. 2013;96:89-95. doi: 10.3168/jds.2012-5863
38. Dominianni C, Sinha R, Goedert JJ, Pei Z, Yang L, Hayes RB, Ahn J. Sex, body mass index, and dietary fber intake infuence the human gut micro-biome. PLoS One. 2015;10:e0124599. doi: 10.1371/journal.pone.0124599
39. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102:11070-11075. doi: 10.1073/pnas.0504978102
40. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, Gómez-Delgado F, Pérez-Martínez P, Delgado-Lista J, Quintana-Navarro GM, Landa BB, Navas-Cortés JA, Tena-Sempere M, Clemente JC, López-Miranda J, Pérez-Jiménez F, Camargo A. Intestinal microbiota is infuenced by gender and body mass index. PLoS One. 2016;11:e0154090. doi: 10.1371/journal.pone.0154090
41. Le Chatelier E, Nielsen T, Qin J, et al; MetaHIT Consortium. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500:541-546. doi: 10.1038/nature12506
42. Srinivasan S, Yeh M, Danziger EC, Hatley ME, Riggan AE, Leitinger N, Berliner JA, Hedrick CC. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res. 2003;92:371-377. doi: 10.1161/01.RES.0000061714.74668.5C
43. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr, Luster AD, Luscinskas FW, Rosenzweig A. MCP-1 and IL-8 trigger frm adhesion of monocytes to vascular endothelium under fow conditions. Nature. 1999;398:718-723. doi: 10.1038/19546
44. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the de-velopment of atherosclerosis in ApoE-defcient mice. Arterioscler Thromb Vasc Biol. 1999;19:734-742.
45. Sprague AH, Khalil RA. Infammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol. 2009;78:539-552. doi: 10.1016/j.bcp.2009.04.029
46. Härle P, Straub RH. Leptin is a link between adipose tissue and infamma-tion. Ann NY Acad Sci. 2006;1069:454-462. doi: 10.1196/annals.1351.044
47. Iikuni N, Lam QL, Lu L, Matarese G, La Cava A. Leptin and infammation. Curr Immunol Rev. 2008;4:70-79. doi: 10.2174/157339508784325046
48. Yang WH, Liu SC, Tsai CH, Fong YC, Wang SJ, Chang YS, Tang CH. Leptin induces IL-6 expression through OBRl receptor signaling path-way in human synovial fbroblasts. PLoS One. 2013;8:e75551. doi: 10.1371/journal.pone.0075551
49. Tang CH, Lu DY, Yang RS, Tsai HY, Kao MC, Fu WM, Chen YF. Leptin-induced IL-6 production is mediated by leptin receptor, insulin receptor substrate-1, phosphatidylinositol 3-kinase, Akt, NF-kappaB, and p300 pathway in microglia. J Immunol. 2007;179:1292-1302.
50. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Böhm M, Nickenig G. Interleukin-6 induces oxidative stress and endothelial dys-function by overexpression of the angiotensin II type 1 receptor. Circ Res. 2004;94:534-541. doi: 10.1161/01.RES.0000115557.25127.8D
51. Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999;194:6-11. doi: 10.1006/cimm.1999.1490
52. Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinfammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-1131. doi: 10.1056/NEJMoa1707914
53. Bugaut M. Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. Comp Biochem Physiol B. 1987;86:439-472.
54. Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. Physiol Genomics. 2016;48:826-834. doi: 10.1152/physiolgenomics.00089.2016
55. Miyamoto J, Hasegawa S, Kasubuchi M, Ichimura A, Nakajima A, Kimura I. Nutritional signaling via free fatty acid receptors. Int J Mol Sci. 2016;17:450. doi: 10.3390/ijms17040450
56. Pluznick JL. Renal and cardiovascular sensory receptors and blood pressure regulation. Am J Physiol Renal Physiol. 2013;305:F439-F444. doi: 10.1152/ajprenal.00252.2013
57. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell ac-tivation. J Biol Chem. 2003;278:25481-25489. doi: 10.1074/jbc. M301403200
58. Ang Z, Er JZ, Tan NS, Lu J, Liou YC, Grosse J, Ding JL. Human and mouse monocytes display distinct signalling and cytokine profles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci Rep. 2016;6:34145. doi: 10.1038/srep34145
59. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science. 2013;339:1084-1088. doi: 10.1126/science.1233521
60. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022-1023. doi: 10.1038/4441022a
61. Nelson KE, Weinstock GM, Highlander SK, et al. A catalog of reference genomes from the human microbiome. Science. 2010;328:994-999.
62. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, Gordon JI, Knight R. Moving pictures of the human microbiome. Genome Biol. 2011;12:R50. doi: 10.1186/gb-2011-12-5-r50
63. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694-1697. doi: 10.1126/science.1177486
64. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5:e9836. doi: 10.1371/journal.pone.0009836
65. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220-230. doi: 10.1038/nature11550